Ligand Pharmaceuticals
LGND
#2816
Rank
A$8.81 B
Marketcap
A$439.90
Share price
2.59%
Change (1 day)
151.75%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): A$0.24 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are A$0.26 Billion. , an increase over its 2024 earnings that were of A$8.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 A$0.23 B2848.57%
2024 A$8.04 M-91.37%
2023 A$93.19 M-7.59%
2022 A$0.10 B4%
2021 A$96.97 M296.42%
2020 A$24.46 M-97.97%
2019 A$1.20 B275.62%
2018 A$0.32 B237.48%
2017 A$95.14 M49.05%
2016 A$63.83 M55.41%
2015 A$41.07 M36.87%
2014 A$30.01 M29.59%
2013 A$23.15 M1309.35%
2012 A$1.64 M-43.97%
2011 A$2.93 M-113.19%
2010 -A$22.24 Million59.86%
2009 -A$13.91 Million-61.33%
2008 -A$35.97 Million-58.75%
2007 -A$87.2 Million20.52%
2006 -A$72.35 Million81.27%
2005 -A$39.92 Million
2003 -A$27.79 Million-20.6%
2002 -A$35 Million4.38%
2001 -A$33.53 Million-48.83%
2000 -A$65.52 Million-19.74%
1999 -A$81.63 Million-19.06%
1998 -A$0.11 Billion126.71%
1997 -A$44.49 Million-5.83%
1996 -A$47.24 Million136.23%
1995 -A$20 Million-33.97%
1994 -A$30.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.64 B 15,772.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$15.34 B 6,370.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$45.10 B 18,916.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$13.16 B 5,451.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.74 Billion-410.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$19.05 B 7,935.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.90 B 5,763.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.50 B 6,016.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-A$89.67 Million-137.81%๐Ÿ‡บ๐Ÿ‡ธ USA